Alexandra M. Wilson, PharmD

Senior Clinical Program Pharmacist
Prime Therapeutics

Poster(s):

• (292) Real-World patterns of intravenous immunoglobulin (IVIG) and antimicrobial use in members with multiple myeloma treated with chimeric antigen receptor T-cell (CAR T) or bispecific antibody (BsAbs) therapies
  Wednesday, October 29, 2025

• (321) Total cost of care (TCOC) and adverse effects (AEs) assessment of bispecific T cell engagers (BiTEs) and Chimeric Antigen Receptor T-Cell (CAR T) therapies for relapsed refractory follicular lymphoma (RRFL)
  Wednesday, October 29, 2025